tiprankstipranks
Harvard Bioscience (HBIO)
NASDAQ:HBIO
US Market
HBIO
Harvard Bioscience
RESEARCH TOOLSreports
Want to see HBIO full AI Analyst Report?

Harvard Bioscience (HBIO) Ratios

276 Followers

Harvard Bioscience Ratios

HBIO's free cash flow for Q1 2026 was $0.59. For the 2026 fiscal year, HBIO's free cash flow was decreased by $ and operating cash flow was
gt;-0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.99 2.20 0.82 1.85 2.20
Quick Ratio
 1.06 1.25 0.40 0.92 1.06
Cash Ratio
 0.30 0.39 0.07 0.16 0.19
Solvency Ratio
 -0.08 -0.77 -0.09 0.06 -0.03
Operating Cash Flow Ratio
 0.12 0.31 0.03 0.53 0.05
Short-Term Operating Cash Flow Coverage
 1.82 4.41 0.04 2.39 0.30
Net Current Asset Value
$ -20.41M$ -18.11M$ -18.19M$ -15.25M$ -22.02M
Leverage Ratios
Debt-to-Assets Ratio
 0.57 0.55 0.35 0.31 0.37
Debt-to-Equity Ratio
 4.39 3.22 0.70 0.59 0.75
Debt-to-Capital Ratio
 0.81 0.76 0.41 0.37 0.43
Long-Term Debt-to-Capital Ratio
 0.78 0.72 0.00 0.30 0.37
Financial Leverage Ratio
 7.76 5.83 2.00 1.88 2.01
Debt Service Coverage Ratio
 0.46 0.93 -0.06 0.76 0.10
Interest Coverage Ratio
 0.50 -0.13 -1.94 0.53 -2.72
Debt to Market Cap
 1.47 1.26 0.40 0.16 0.41
Interest Debt Per Share
 10.40 11.08 10.96 1.09 1.37
Net Debt to EBITDA
 21.83 6.71 -27.40 4.79 52.68
Profitability Margins
Gross Profit Margin
57.06%53.01%58.18%58.86%53.66%
EBIT Margin
-3.04%-0.73%-8.98%0.92%-5.85%
EBITDA Margin
1.98%6.14%-1.57%7.16%0.83%
Operating Profit Margin
1.39%-0.73%-6.60%1.69%-6.12%
Pretax Profit Margin
-11.57%-66.30%-12.39%-2.28%-8.10%
Net Profit Margin
-11.44%-65.51%-13.18%-3.04%-8.40%
Continuous Operations Profit Margin
-11.44%-65.51%-13.18%-3.04%-8.40%
Net Income Per EBT
98.84%98.80%106.34%133.61%103.67%
EBT Per EBIT
-834.65%9123.37%187.81%-134.95%132.40%
Return on Assets (ROA)
-12.55%-70.81%-9.80%-2.49%-6.55%
Return on Equity (ROE)
-73.04%-412.84%-19.58%-4.67%-13.18%
Return on Capital Employed (ROCE)
2.19%-1.08%-8.66%1.71%-5.68%
Return on Invested Capital (ROIC)
2.11%-1.04%-5.66%1.60%-5.41%
Return on Tangible Assets
-15.87%-90.18%-20.96%-5.31%-13.98%
Earnings Yield
-39.13%-190.92%-13.50%-1.50%-8.30%
Efficiency Ratios
Receivables Turnover
 5.87 5.39 6.33 6.97 6.78
Payables Turnover
 6.95 11.14 8.22 8.31 8.15
Inventory Turnover
 1.65 1.95 1.69 1.87 1.99
Fixed Asset Turnover
 7.37 18.08 8.38 12.82 12.34
Asset Turnover
 1.10 1.08 0.74 0.82 0.78
Working Capital Turnover Ratio
 3.43 10.54 14.88 4.46 3.53
Cash Conversion Cycle
 230.34 221.61 228.77 203.81 192.75
Days of Sales Outstanding
 62.19 67.66 57.64 52.35 53.80
Days of Inventory Outstanding
 220.70 186.73 215.51 195.36 183.76
Days of Payables Outstanding
 52.55 32.78 44.38 43.90 44.81
Operating Cycle
 282.89 254.39 273.15 247.70 237.56
Cash Flow Ratios
Operating Cash Flow Per Share
 0.63 1.52 0.33 0.33 0.03
Free Cash Flow Per Share
 0.34 1.26 -0.42 0.28 -0.01
CapEx Per Share
 0.29 0.25 0.75 0.05 0.04
Free Cash Flow to Operating Cash Flow
 0.53 0.83 -1.27 0.84 -0.38
Dividend Paid and CapEx Coverage Ratio
 2.15 6.04 0.44 6.07 0.72
Capital Expenditure Coverage Ratio
 2.15 6.04 0.44 6.07 0.72
Operating Cash Flow Coverage Ratio
 0.06 0.15 0.03 0.33 0.02
Operating Cash Flow to Sales Ratio
 0.03 0.08 0.02 0.12 0.01
Free Cash Flow Yield
6.00%18.91%-1.98%5.16%-0.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -2.60 -0.52 -7.41 -66.46 -12.05
Price-to-Sales (P/S) Ratio
 0.30 0.34 0.98 2.02 1.01
Price-to-Book (P/B) Ratio
 2.53 2.16 1.45 3.11 1.59
Price-to-Free Cash Flow (P/FCF) Ratio
 16.94 5.29 -50.39 19.37 -261.90
Price-to-Operating Cash Flow Ratio
 8.99 4.41 63.80 16.18 99.58
Price-to-Earnings Growth (PEG) Ratio
 -0.03 >-0.01 -0.03 1.02 >-0.01
Price-to-Fair Value
 2.53 2.16 1.45 3.11 1.59
Enterprise Value Multiple
 36.94 12.30 -89.72 33.04 174.20
Enterprise Value
 62.24M 65.36M 132.25M 265.44M 164.45M
EV to EBITDA
 36.70 12.30 -89.72 33.04 174.20
EV to Sales
 0.73 0.76 1.40 2.36 1.45
EV to Free Cash Flow
 41.16 11.64 -72.55 22.65 -375.45
EV to Operating Cash Flow
 22.01 9.71 91.84 18.92 142.75
Tangible Book Value Per Share
 -1.39 -0.78 -0.95 >-0.01 -0.12
Shareholders’ Equity Per Share
 2.25 3.09 14.55 1.72 1.74
Tax and Other Ratios
Effective Tax Rate
 0.01 0.01 -0.06 -0.34 -0.04
Revenue Per Share
 19.12 19.50 21.62 2.65 2.74
Net Income Per Share
 -2.19 -12.77 -2.85 -0.08 -0.23
Tax Burden
 0.99 0.99 1.06 1.34 1.04
Interest Burden
 3.81 91.23 1.38 -2.47 1.38
Research & Development to Revenue
 0.10 0.10 0.11 0.10 0.11
SG&A to Revenue
 0.43 0.43 0.46 0.20 0.22
Stock-Based Compensation to Revenue
 <0.01 -0.02 0.05 0.04 0.04
Income Quality
 -0.29 -0.12 -0.12 -4.11 -0.12
Currency in USD